Combination Treatment of Polo-Like Kinase 1 and Tankyrase-1 Inhibitors Enhances Anticancer Effect in Triple-negative Breast Cancer Cells

Geun‐Hyoung Ha(SK Group (South Korea)), Chung Kwon Kim(SK Group (South Korea))
Anticancer Research
March 1, 2018
Cited by 21


Related Papers